Effects of estrogen therapy on hearing in postmenopausal women

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 1, 2004, Pages 77-82

  Kilicdag, Esra Bulgan ^a   Yavuz, Haluk ^a   Bagis, Tayfun ^a,b   Tarim, Ebru ^a   Erkan, Alper Nabi ^a   Kazanci, Ferah ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Guzelyali Mah Adnan Kahveci B   (Turkey)

Author keywords

Estrogen therapy; Hearing loss; Hormone therapy; Postmenopausal

Indexed keywords

ADULT; ARTICLE; AUDIOMETRY; BODY MASS; BONE CONDUCTION; CONTROLLED STUDY; EARDRUM; ESTROGEN THERAPY; FEMALE; HEARING; HUMAN; MAJOR CLINICAL STUDY; OTOSCOPY; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0742269649     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.06.001     Document Type: Article

References (30)

1. Davis AC. Epidemiological profile of hearing impairments: the scale and nature of the problem with special reference to the elderly. Acta Otolaryngol Suppl 1990;476:23-31.
2. Coleman JR, Campbell D, Cooper A, Welch MG, Moyer J. Auditory brainstem response after ovariectomy and estrogen replacement in rat. Hear Res 1994;80:209-15.
3. Stenberg AE, Wang H, Fish J 3d, Schrott-Fisher A, Sahlin L, Hultcrantz M. Estrogen receptors in the normal adult and developing human ear and in Turner's syndrome. Hear Res 2001; 157:87-92.
4. Hultcrantz M, Stenberg AE, Fransson A, Canlon B. Characterization of hearing in an X, 0 Turner mouse. Hear Res 2000;143:182-8.
5. Stenberg AE, Wang H, Sahlin L, Stierna P, Enmark E, Hultcrantz M. Estrogen receptors α and β in the inner ear of the Turner mouse and an estrogen receptor β knockout mouse. Hear Res 2002;166:1-8.
6. Jerger J, Johnson K. Interactions of age, gender, and sensorineural hearing loss on ABR latency. Ear Hear 1988;9:168-76.
7. Wharton JA, Church GT. Influence of menopause on the auditory brainstem response. Audiology 1990;9:196-201.
8. Elkind-Hirsch KE, Wallace E, Malinak LR, Jerger JJ. Sex hormones regulate ABR latency. Otolaryngol Head Neck Surg 1994;110:46-52.
9. Pettersson K, Gustafsson A. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001;63:165-92.
10. Beyer C. Estrogen and the developing mammalian brain. Anat Embryol (Berl) 1999;199:379-90.
11. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
12. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60.
13. Jerger J, Hall J. Effects of age and sex on auditory brainstem response. Arch Otolaryngol 1980;106:387-91.
14. Elkind-Hirsch KE, Stoner WR, Stach BA, Jerger JF. Estrogen influences auditory brainstem responses during the normal menstrual cycle. Hear Res 1992;60:143-8.
15. Miller MH, Gould WJ. Fluctuating sensorinerual hearing impairment associated with the menstrual cycle. J Audiolog Res 1967;7: 373-85.
16. Andreyko JL, Jaffe RB. Use of a gonadotropinreleasing hormone agonist analogue for treatment of cyclic auditory dysfunction. Obstet Gynecol 1989;74:506-9.
17. Fausti SA, Frey RH, Erickson DA, Rappaport BZ, Cleary EJ. A system for evaluating auditory function from 8000-20000 Hz. J Acoust Soc Am 1979;66:1713-8.
18. Tonndorf J, Kurman B. High frequency audiometry. Ann Otol Rhinol Laryngol 1984;93:576-82.
19. Hinchcliffe R. The age function of hearing: aspects of the epidemiology. Acta Otolaryngol 1991;476:7-11.
20. Schuhnecht HF. Further observations on the pathology of presbycousis. Arch Otolaryngol 1964;80:373-82.
21. Rudzinski W, Kejza H. Effects of estrogens on the brain and implications for nero-protection. Neurol Neurochir Pol 2002;36: 143-56.
22. Wang L, Andersson S, Warner M, Gustafsson J. Morphological abnormalities in the brains of receptor β knockout mice. Neurobiology 2001;98:2792-6.
23. Kucharczyk J. Neuroendocrine mechanism mediating fluid intake during the estrous cycle. Brain Res Bull 1984;12:175-80.
24. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60.
25. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimers Disease Cooperative Study. JAMA 2000;283: 1007-15.
26. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000;54:295-301.
27. Shaw TG, Mortel KF, Meyer JS, Rogers RL, Hardenberg J, Cutaita MM. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 1984;34:855-62.
28. Rodriguez G, Warkentin S, Risberg J, Rosadini G. Sex differences in regional cerebral blood flow. J Cereb Blood Flow Metab 1988;8: 783-9.
29. Shay J, Futo J, Badrov N, Moss J. Estrogen withdrawal selectively increases serotonin serotonin reactivity in rabbit basilar artery. Life Sci 1994;55:1071-81.
30. Laugel GR, Dengerink HA, Wright JW. Ovarian steroid and vasoconstrictor effects on cochlear blood flow. Hear Res 1987;31: 245-51.